[ACTION OF MITOMYCIN C IN 65 CASES OF MALIGNANT TUMOR. COMPARISON OF REPEATED SMALL DOSES AND "MASSIVE" DOSES].
D000230:Adenocarcinoma; D008949:Adenoma, Pleomorphic; D000970:Antineoplastic Agents; D002294:Carcinoma, Squamous Cell; D056486:Chemical and Drug Induced Liver Injury; D003520:Cyclophosphamide; D005354:Fibrosarcoma; D006505:Hepatitis; D006801:Humans; D007275:Injections, Intravenous; D008545:Melanoma; D008654:Mesothelioma; D016685:Mitomycin; D009101:Multiple Myeloma; D009369:Neoplasms / Q000453:epidemiology*; D009447:Neuroblastoma; D013724:Teratoma; D014116:Toxicology
D000970:Antineoplastic Agents; D016685:Mitomycin; D003520:Cyclophosphamide
ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; CARCINOMA, EPIDERMOID; CYCLOPHOSPHAMIDE; FIBROSARCOMA; HEPATITIS, TOXIC; INJECTIONS, INTRAVENOUS; MELANOMA; MESOTHELIOMA; MITOMYCIN; MIXED SALIVARY GLAND TUMOR; MULTIPLE MYELOMA; NEOPLASM STATISTICS; NEUROBLASTOMA; TERATOID TUMOR; TOXICOLOGIC REPORT
ACTION DE LA MITOMYCINE C DANS 65 CAS DE TUMEURS MALIGNES. COMPARAISON DE L'EFFET DE DOSES FAIBLES, R'EP'ET'EES ET DE DOSES.